Mezzion Pharma largest shareholder Park Dong Hyun voting stake falls to 18.59% from 27.06% filing shows

• Mezzion disclosed a drop in voting rights held by chairman Park Dong Hyun and related parties to 5,692,451 shares, 18.59%, from 27.06%.
• The change was triggered by the termination of a shareholder agreement, reducing the number of related parties to six from eight.
• Shares tied to key contracts fell to 2,913,093 shares, 9.51%, from 24.01%.
• The disclosure was dated Oct. 2, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mezzion Pharma Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261002000671), on October 02, 2026, and is solely responsible for the information contained therein.